Zdrowie i gospodarka · 16/02/2018

FDA Releases Draft Guidance for Early Alzheimer's Disease Treatment

The Food and Drug Administration (FDA) has made available a draft guidance document to help pharmaceutical companies develop drugs for treating early stages of Alzheimer's disease, a condition that affects millions of Americans, before symptoms of dementia become apparent.